Ruud P M Dings
Overview
Explore the profile of Ruud P M Dings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
2078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jamshidi-Parsian A, Jenkins S, Tran A, Bragg A, Davis R, Griffin C, et al.
Eur J Pharmacol
. 2024 Aug;
982:176912.
PMID: 39159716
Glutaminase inhibitors are currently being explored as potential treatments for cancer. This study aimed to elucidate the molecular mechanisms underlying the effects of CB-839 on lung tumor cell lines compared...
2.
Ippel H, Miller M, Dings R, Ludwig A, Gabius H, Mayo K
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000066
Galectins are multifunctional effectors in cellular homeostasis and dysregulation. Oxidation of human galectin-1 (Gal-1) with its six sulfhydryls produces a disulfide-bridged oxidized form that lacks normal lectin activity yet gains...
3.
Jenkins S, Johnsrud A, Dings R, Griffin R
Semin Radiat Oncol
. 2024 Jun;
34(3):284-291.
PMID: 38880537
The standard of care for radiation therapy is numerous, low-dose fractions that are distributed homogeneously throughout the tumor. An alternative strategy under scrutiny is to apply spatially fractionated radiotherapy (high...
4.
Jenkins S, Shah S, Jamshidi-Parsian A, Mortazavi A, Kristian H, Boysen G, et al.
Radiat Res
. 2024 Feb;
201(2):174-187.
PMID: 38329819
Resistance to radiation remains a significant clinical challenge in non-small cell lung carcinoma (NSCLC). It is therefore important to identify the underlying molecular and cellular features that drive acquired resistance....
5.
Jenkins S, Jung S, Jamshidi-Parsian A, Borrelli M, Dings R, Griffin R
ACS Appl Mater Interfaces
. 2023 Dec;
15(50):58241-58250.
PMID: 38059477
Gold nanomaterials have been shown to augment radiation therapy both in vitro and in vivo. However, studies on these materials are mostly phenomenological due to nanoparticle heterogeneity and the complexity...
6.
Nowak-Sliwinska P, van Beijnum J, Griffioen C, Huinen Z, Sopesens N, Schulz R, et al.
Angiogenesis
. 2022 Dec;
26(2):279-293.
PMID: 36459240
Purpose: Ongoing angiogenesis renders the tumor endothelium unresponsive to inflammatory cytokines and interferes with adhesion of leukocytes, resulting in escape from immunity. This process is referred to as tumor endothelial...
7.
Dings R, Kumar N, Mikkelson S, Gabius H, Mayo K
Biochem Biophys Rep
. 2021 Sep;
28:101116.
PMID: 34485713
Background: Even though members of the family of adhesion/growth-regulatory galectins are increasingly detected to be co-expressed, they are still being routinely tested separately. The recent discovery of heterodimer formation among...
8.
Safina I, Al Sudani Z, Hashoosh A, Darrigues E, Watanabe F, Biris A, et al.
PLoS One
. 2021 Aug;
16(8):e0241882.
PMID: 34460818
Gold nanoparticles (AuNPs) hold great promise in nanomedicine, yet their successful clinical translation has not been realized. Some challenges include effective AuNP targeting and delivery to improve modulation of immune...
9.
Jenkins S, Alimohammadi M, Terry A, Griffin R, Tackett A, Leung J, et al.
Angiogenesis
. 2021 Feb;
24(3):597-611.
PMID: 33629198
Antibiotic-induced microbial imbalance, or dysbiosis, has systemic and long-lasting effects on the host and response to cancer therapies. However, the effects on tumor endothelial cells are largely unknown. Therefore, the...
10.
Safina I, Alghazali K, Childress L, Griffin C, Hashoosh A, Kannarpady G, et al.
J Appl Toxicol
. 2021 Jan;
41(9):1456-1466.
PMID: 33417269
The use of synthetic materials for biomedical applications is ever expanding. One of the major requirements for these materials is biocompatibility, which includes prevention of immune system responses. Due to...